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Clinical metagenomics is actively moving from research to clinical laboratories. It has
the potential to change the microbial diagnosis of infectious diseases, especially when
detection and identification of pathogens can be challenging, such as in prosthetic
joint infection (PJI). The application of metagenomic sequencing to periprosthetic joint
tissue (PJT) specimens is often challenged by low bacterial load in addition to high
level of inhibitor and contaminant host DNA, limiting pathogen recovery. Shotgun-
metagenomics (SMg) performed directly on positive blood culture bottles (BCBs)
inoculated with PJT may be a convenient approach to overcome these obstacles. The
aim was to test if it is possible to perform SMg on PJT inoculated into BCBs for pathogen
identification in PJI diagnosis. Our study was conducted as a laboratory method
development. For this purpose, spiked samples (positive controls), negative control and
clinical tissue samples (positive BCBs) were included to get a comprehensive overview.
We developed a method for preparation of bacterial DNA directly from PJT inoculated in
BCBs. Samples were processed using MolYsis5 kit for removal of human DNA and DNA
extracted with BiOstic kit. High DNA quantity/quality was obtained, and no inhibition
was observed during the library preparation, allowing further sequencing process. DNA
sequencing reads obtained from the BCBs, presented a low proportion of human reads
(<1%) improving the sensitivity of bacterial detection. We detected a 19-fold increase in
the number of reads mapping to human in a sample untreated with MolYsis5. Taxonomic
classification of clinical samples identified a median of 96.08% (IQR, 93.85–97.07%;
range 85.7–98.6%) bacterial reads. Shotgun-metagenomics results were consistent
with the results from a conventional BCB culture method, validating our approach.
Overall, we demonstrated a proof of concept that it is possible to perform SMg directly
on BCBs inoculated with PJT, with potential of pathogen identification in PJI diagnosis.
We consider this a first step in research efforts needed to face the challenges presented
in PJI diagnoses.
Keywords: shotgun-metagenomics, clinical metagenomics, prosthetic joint infection, blood culture bottles,
prosthetic joint tissue
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INTRODUCTION
Metagenomic next-generation sequencing (mNGS) refers to
shotgun sequencing of all available DNA and/or RNA in
a sample followed by the precise taxonomic identification
and classification of each sequence (Couto et al., 2018;
Rutanga et al., 2018). The application of shotgun metagenomics
(SMg) to clinical samples to recover information of clinical
relevance is emerging and it is known as clinical metagenomics
(Forbes et al., 2018).
Shotgun-metagenomics has a huge potential, particularly in
areas where conventional diagnostic methods have limitations
such as in prosthetic joint infection (PJI) (Thoendel et al.,
2018). It is a promising approach opening huge opportunities for
detecting, identifying and characterizing all potential pathogens,
providing at the same time additional inputs on important
characteristics for clinical management, such as antibiotic
resistance determinants, virulence factors, and bacterial evolution
(Wilson et al., 2019).
To date, several studies have provided evidence of the
potential and successful applications of clinical metagenomics in
a variety of clinical specimens including urine (Hasman et al.,
2014; Schmidt et al., 2017), respiratory secretions (Nakamura
et al., 2009; Bogaert et al., 2011; Schlaberg et al., 2017; Langelier
et al., 2018), cerebrospinal fluid (Schlaberg et al., 2017; Miller
et al., 2019), stool (Zhou et al., 2016), blood (whole blood, serum,
and plasma), and tissue (Ruppé et al., 2017). Several reviews
have summarized the advances, limitations and challenges in
the field (Padmanabhan et al., 2013; Simner et al., 2018;
Chiu and Miller, 2019).
There are many issues that need to be addressed before
performing clinical metagenomics in real time directly from
clinical samples as an integral part of routine diagnostic testing.
Among them are the technical challenges related to sample
preparation protocols, to process and analyze clinical specimens.
In this regard, it is important to consider that different specimen
types present their unique and specific challenges reflecting
their matrix and concentrations of the target pathogen(s) and
normal (resident) flora (Bachmann et al., 2018). Therefore,
when performing sequencing directly from a clinical sample,
special attention has to be paid to (1) contamination of host
DNA and other microorganisms, (2) low abundance of the
target organism present in the sample and (3) the presence of
DNA amplification inhibitors and other sample variables (i.e.,
sample type, matrix) (Mulcahy-O’Grady and Workentine, 2016;
Bachmann et al., 2018).
Prosthetic joint infection (PJI) is a serious complication after
joint implantation, occurring in 1–2% of primary arthroplasties
and 4% in revision arthroplasties (Ong et al., 2009; Corvec
et al., 2012; Izakovicova et al., 2019). The infection is associated
with high morbidity rates and diagnosis is challenging due to
Abbreviations: ATCC, American type culture collection; BCBs, Blood culture
bottles; ENA, European Nucleotide Archive; IQR, Interquartile ranges; MALDI-
TOF, Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry;
mNGS, metagenomic next-generation sequencing; PJI, Prosthetic joint infection;
PJT, Periprosthetic joint tissue; SMg, Shotgun-metagenomics; WGS, Whole
genome sequencing.
imperfect definition and imperfect diagnostic techniques (Tande
and Patel, 2014; Park and Patel, 2018). Undiagnosed PJI cases due
to culture-negatives have been estimated to a proportion of 10–
30%, for example due to ongoing empirical antibiotic treatment
(Tande and Patel, 2014; Peel et al., 2016). Culturing the causative
pathogen takes longer time and is problematic in less virulent,
fastidious and slow growing organisms (Schafer et al., 2008).
The diagnosis of PJI is not standardized (Parvizi et al., 2011).
However, the microbiological assessment of periprosthetic tissue
is the most important method and to date the gold standard
for diagnosing PJI (Parvizi et al., 2011; Yan et al., 2018). Due
to low sensitivity and specificity, rapid and accurate diagnosis
is still a challenge. Additionally, methods for rapid pathogen
identification directly on clinical samples such as multiplex
PCR, MALDI-TOF and whole genome sequencing (WGS) have
been developed (Greenwood-Quaintance et al., 2014; Patel, 2015;
Tagini and Greub, 2017). However, they are still dependent
on pure microbial culture in addition to the fact that some
of them do not give information beyond species identification
(Török et al., 2013). Research and development of new diagnostic
methods that overcome these limitations are required.
In a previous study, we assessed the use of a BacT/Alert R©
Virtuo blood culture system for culturing periprosthetic tissue
specimens (Sanabria et al., 2019). The blood culture bottle
(BCB) method was found to detect a wider range of bacteria
more rapidly than the conventional microbiological method.
Furthermore, previous studies have demonstrated the potential
of microbiological detection using BCBs for culturing specimens
related to PJI, such as synovial fluid (Hughes et al., 2001; Font-
Vizcarra et al., 2010), sonication fluid (Portillo et al., 2015; Shen
et al., 2015; Janz et al., 2016; Dudareva et al., 2018), and prosthetic
joint tissue (PJT) (Velay et al., 2010; Minassian et al., 2014; Peel
et al., 2016, 2017; Dudareva et al., 2018). The evaluation of SMg
in the diagnosis of PJI remains limited (Zhang et al., 2019). To
date, studies have investigated the application of SMg on tissue
specimens (Ruppé et al., 2017), synovial fluid (Ivy et al., 2018) and
sonication fluid (Thoendel et al., 2016, 2017, 2018; Street et al.,
2017; Sanderson et al., 2018; Yan et al., 2019), where the main
obstacle has been a high background of genetic material mainly
derived from the host, hampering the detection of pathogens
(Zhang et al., 2019).
So far, there are no studies about SMg on BCBs inoculated with
any specimens related to PJI. We believe that the combination
of inoculation of BCBs with PJT specimens followed by direct
DNA sequencing may be a beneficial strategy. Here, we developed
a proof of concept study with the aim of evaluating the use of
SMg on BCBs inoculated with PJT for pathogen identification
in diagnosis of PJI. Our study was conducted as a laboratory
method development, including PJT specimens and appropriate
controls. The aim was to test if SMg technology works on
this specific type of specimens, and for this purpose develop a
method for preparation of high-quality bacterial DNA from PJT
for downstream SMg, establish a bioinformatics pipeline, and
compare SMg results with conventional culture method results.
SMg was performed to investigate if it was possible to obtain an
acceptable high number of bacterial reads, genome coverage and
genome sequencing depth for identification of PJI pathogens.
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MATERIALS AND METHODS
Ethics Statement
This study was performed in accordance with the ethical
guidelines established by The Arctic University of Norway (UiT).
The project has been evaluated by the Regional Committee
for Medical and Health Research Ethics, Rec North, Norway
(document no. 2016/1247/REK nord), concluding that ethical
approval was not required. There were no ethical issues
to consider due to use of anonymous clinical samples and
development of methodological procedures.
Sample Collection
A sample collection of positive BCBs was obtained from a
previous study, where we evaluated the use of Bact/Alert R© BCBs
(bioMérieux, Marcy l’Etoile, France) for culturing PJT (Sanabria
et al., 2019). In brief, three different types of BCB samples were
obtained during that study: BCBs inoculated with PJT clinical
samples from patients with suspicion of PJI, BCBs inoculated
with tissue spiked with bacterial species reported as common
microbiological causes of PJI and a negative control which was
prepared by inoculating sterilized tissue (irradiated to 25 Gy)
from a crushed native femoral head. For further details on the
BCB sample preparation method, see Sanabria et al. (2019).
Bact/Alert R© BCBs were enriched with 4 mL of horse
blood, which has previously been shown to produce high
positivity rates and shortening of time to detection (Nylén
et al., 2013) and the PJT was analyzed in parallel with the
conventional diagnostic method. Bacterial identification was
performed using matrix-assisted laser desorption ionization-
time of flight mass spectrometry (MALDI-TOF R© MS Bruker
Daltonics – microflexTM).
In this study, 25 positive aerobic BCBs (BacT/Alert FA Plus)
inoculated with PJT were used initially to test two different
DNA sample preparation methods. Subsequently, DNA from
nine BCBs were selected for SMg. Selection criteria included:
samples with presence of a single species of microorganism
(monomicrobial) reported as common microbiological cause of
PJI and high quality/quantity of total DNA concentration of
at least 1 ng/µL bacterial DNA. Samples sequenced included:
samples with Staphylococcus aureus (n = 6), Staphylococcus
epiderimidis (n = 2), Enterococcus faecalis (n = 1), negative control
(NC, n = 1), and spiked samples (positive controls, PC1-3)
(n = 3). The negative control contained DNA extracted from a
BCB enriched with horse blood and inoculated with sterilized
tissue (irradiated to 25 Gy) from a donor with no suspicion
of infection. The three spiked samples were BCBs inoculated
with tissue spiked with a suspension of approximately 90–150
CFU/mL of Escherichia coli ATCC 25922, S. aureus ATCC 25923,
or S. aureus ATCC 25923, and Cutibacterium acnes (clinical
sample), respectively.
In addition, DNA from one of the nine clinical samples was
sequenced three times (sample 1: S1a, S1b, S1c) in order to
evaluate the impact of the sample preparation method on the
metagenomic results, and to determine a suitable number of
samples that could be multiplexed in one lane on the flow cell
during the sequencing process.
Figure 1 gives an overview of the number of samples and the
sample types included in each step of the process. An overview
of all the samples sequenced through SMg, including the controls
and their features are listed in Table 1.
DNA Preparation
Total gDNA was extracted from the blood culture bottles
using the QIAamp BiOstic Bacteremia DNA Kit (Qiagen,
Hilden, Germany). Samples were pre-treated using MolYsisTM
Basic5 kit (Molzym, Bremen, Germany) to deplete human
DNA from the samples before DNA extraction. In order to
find the most suitable procedure for extracting DNA from
BCBs, DNA was extracted with or without pretreatment with
the MolYsis5 kit. Sample pre-treatment and DNA extraction
methods were according to the manufacturer’s instructions and
the procedures were evaluated on the basis of DNA quantity
and quality. Total DNA concentration was measured using
a Qubit dsDNA HS Assay Kit (Life Technologies, Carlsbad,
CA, United States) and DNA quality (OD260/OD280 and
OD260/OD230) determined by Nanodrop.
qPCR
Each DNA sample was fold diluted 1:100 and 1:1000 after
determining these as suitable dilution factors to avoid inhibition
during amplification. Bacterial DNA concentration was
calculated by qPCR targeting the 16S rDNA gene. The standard
curve consisted of a 10-fold dilution series of a mix of gDNA
from bacterial species common to PJI: S. aureus ATCC25923,
E. coli ATCC25922 and S. epidermidis ATCC 12228. The primers
and the probe used were as follows: forward primer 5′-CGA AAG
CGT GGG GAG CAA A-3′; reverse primer 5′-GTT CGT ACT
CCC CAG GCG G-3′; probe 5′-(FAM)-ATT AGA TAC CCT
GGT AGT CCA-(MGB)-3′ (Bogaert et al., 2011). The 20-µL
PCR master mix consisted of 2X TaqMan Universal master mix
II with UNG, 10 µM of each primer (0.8 µL), 5 µM MGB probe
(0.8 µL), 2.6 µL DNA free water, and 5 µL of template DNA
(Cremers et al., 2014).
Before adding the DNA template, 1M DTT and dsDNase
(0.5 µL) from PCR decontamination kit (ArcticZymes, Tromsø,
Norway) were added. Samples were then decontaminated by
incubation at 37◦C for 20 min followed by 60◦C for 20 min
to inactivate the dsDNase. Amplification was preformed using
a 7300 Real-time PCR system (Applied Biosystems, Foster City,
CA 94404 USA) under the following conditions: 50◦C for 2 min,
95◦C for 10 min, 50 cycles of 95◦C for 15 s and 60◦C for 1 min.
The gDNA samples were stored at−20◦C until further use.
Metagenomic Sequencing
Sequencing libraries were prepared using the ThruPLEX R©
DNA-seq Kit (Rubicon Genomics, United States) following the
manufacturer’s instructions. Approximately 100 ng of DNA was
used as input for library preparation from the clinical and spiked
samples, while for the negative control, a little more than 1 ng was
used. The sequencing process was performed at the Norwegian
Sequencing Centre, Oslo, using a MiSeq sequencer (Illumina Inc.,
San Diego, CA, United States) with v2 chemistry and 500 cycles
for 250 bp paired-end sequencing. Samples were multiplexed
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FIGURE 1 | Overview of the number of samples included in each step of the process. aDNA from a BCB sample untreated with molYsis5. Treated: BCB samples
pre-treated with MolYsis5 before DNA extraction. Untreated: BCB samples with no pretreatment with MolYsis5 before DNA extraction.
TABLE 1 | Description of samples sequenced through SMg.
Sample Sample type inoculated in BCB DNA preparation method Microorganism identified Laboratorya (MALDI-TOF)
No Code BCB Conventional
1 S1a PJT (clinical sample) MolYsis5 + BiOstic S. aureus S. aureus
S1b PJT (clinical sample) MolYsis5 + BiOstic S. aureus S. aureus
S1c PJT (clinical sample) BiOstic S. aureus S. aureus
2 S2 PJT (clinical sample) MolYsis5 + BiOstic S. aureus S. aureus
3 S3 PJT (clinical sample) MolYsis5 + BiOstic S. aureus S. aureus
4 S4 PJT (clinical sample) MolYsis5 + BiOstic S. aureus S. aureus
5 S5 PJT (clinical sample) MolYsis5 + BiOstic S. aureus S. aureus
6 S6 PJT (clinical sample) MolYsis5 + BiOstic E. faecalis E. faecalis
7 S7 PJT (clinical sample) MolYsis5 + BiOstic S. aureus No growth
8 S8 PJT (clinical sample) MolYsis5 + BiOstic S. epidermidis No growth
9 S9 PJT (clinical sample) MolYsis5 + BiOstic S. epidermidis No growth
10 PC1 Tissue spiked with S. aureus MolYsis5 + BiOstic S. aureus NA
11 PC2 Tissue spiked with E. coli MolYsis5 + BiOstic E. coli NA
12 PC3 Tissue spiked with S. aureus and C. acnes MolYsis5 + BiOstic S. aureus NA
13 NC Tissue sterile BiOstic NA NA
aResults from our previous study (Sanabria et al., 2019) including BCB method and conventional method. S1–S9, clinical samples; PC1-3, spiked samples (positive
controls); NC, negative control; NA, not applicable.
with 3 or 4 samples per lane. To estimate how many samples
could be multiplexed in one MiSeq lane, one of the samples was
run on a single lane in a pilot assay.
Bioinformatic Data Analysis
The bioinformatic analysis can be summarized in two main
steps: reads preprocessing (Figure 2A) and taxonomic
analyses (Figure 2B).
Obtained raw reads were checked for quality using FastQC
software v0.11.81. Optical duplicates in fastq files were removed
using the program Clumpify v38.36 from BBTools suite2 with
default parameters. Adapter sequences were trimmed off and
the poor-quality reads were removed using BBDuk of BBTools
1http://www.bioinformatics.babraham.ac.uk/projects/fastqc/
2https://jgi.doe.gov/data-and-tools/bbtools/
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FIGURE 2 | Workflow summarizing the bioinformatic analysis in this study. (A) Reads preprocessing. (B) Taxonomic classification and sample composition
estimation.
suite. The minimal length and Phred score were set to 50 and
20 nucleotides, respectively. Contaminant DNA was identified
and removed by mapping all reads against the reference
genomes of human GRCh38.p13 (GCF_000001405.39), horse
(GCF_002863925.1) and the PhiX phage (Escherichia virus
phiX174, GCF_000819615.1) using Bowtie2 aligner in FastQ
Screen v0.13.0 (Wingett and Andrews, 2018).
Preprocessed PE reads were classified using two established
tools for taxonomic profiling of metagenomic samples: Kraken
(Salzberg and Wood, 2014), which is based on exact alignments
of genomic k-mers, and MetaPhlAn2 which is based on clade-
specific marker genes (Segata et al., 2012). However, in this work
we have chosen to focus more on the Kraken analyses.
Taxonomic classification with MetaPhlAn2 v2.7.7 was
executed with default parameters and using the database
provided by the tool, as of July 2019. Taxonomic classification
with Kraken v1.1.1 was performed using default parameters
against the 8 GB dustmasked miniKraken database constructed
from bacterial, archaeal, and viral genomes in Refseq, as
of Oct. 18, 2017. Re-estimation of abundance was done
using Bracken (Lu et al., 2017). The same pipeline for
taxonomical assignment and species abundance estimation
was applied to all the samples after downsizing the number
of reads by randomly sampling (using SeqKit v0.11.0.)
a proportion of reads from the full dataset. Subsamples
from 10 to 100% of the reads were extracted and analyzed.
In addition, the effect of setting a threshold for species
detection level when using Kraken classifier, was evaluated
by setting different threshold values (0, 10, 100, 500, 1000,
1500, 2500, 3000, 3500, and 4000 reads) on the spiked and
clinical samples.
Finally, as a control to test false taxonomic assignments by
Kraken, sequence reads belonging to the spiked samples and
the negative control were aligned against reference genomes
belonging to the top species hits from Kraken classification,
using Burrows–Wheeler aligner-maximum exact matches (BWE-
MEM) v0.7.17 (Li and Durbin, 2009).
Statistical Analysis
Descriptive statistics for categorical variables were
based on percentages and frequencies, while continuous
variables were based on means, standard deviations
(SDs), medians and interquartile ranges (IQRs). In
addition, Wilcoxon rank sum test was used to evaluate
if the differences between the DNA sample preparation
methods were statistically significant. The differences
were considered statistically significant with P-values
lower than 0.05. Data were analyzed utilizing GraphPad
Prism software, version 8.3.0 (GraphPad Software Inc.,
CA, United States).
Classification results from the metagenomics experiments
were explored using the Pavian R package version 0.8.4
(Breitwieser and Salzberg, 2019) by using their data tables,
heatmaps, and Sankey flow diagrams.
RESULTS
Establishment of Method for Bacterial
DNA Isolation From BCBs Inoculated
With PJT
Since there is no standard procedure for the isolation of DNA
from BCBs inoculated with PJT, we initially examined the
performance of QIAamp BiOstic Bacteremia DNA Kit pre-
treated and untreated with the MolYsis basic5 kit.
DNA from 25 positive BCBs (BacT/Alert R© FA Plus, aerobic
bottles) were isolated using the BiOstic kit with or without
pretreatment with MolYsis5. Comparison between the two
methods was based on the total DNA yield and the DNA
quality (Supplementary Table S1). DNA concentration
measurements showed that samples treated with MolYsis5
yielded a higher mean DNA concentration (DNA 84.23
ng/µL, p = 0.0069), than untreated samples (65.28 ng/µL)
(Supplementary Tables S2, S3). Both procedures yielded
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relatively pure DNA with median absorbance ratios of 1.81
(IQR = 1.67–1.90) and 1.88 (IQR = 1.8–2.02), respectively
(Supplementary Figures S1A,B).
In order to evaluate the level of bacterial DNA within
total DNA, qPCR was performed. Amplification on undiluted
DNA extracts failed to amplify in all the cases, while
amplification of DNA diluted 1:100 and 1:1000, revealed
that the average bacterial DNA concentration was 21.35
ng/µL in untreated samples and 28.53 ng/µL in the MolYsis
treated samples (Supplementary Figures S1C,D). All DNA
samples contained at least 1 pg bacterial DNA/µL meeting
the requirements needed to be considered eligible for SMg.
DNA from negative controls contained 0.79% (3.6 pg/µL)
and 0.04% (0.2 pg/µL) bacterial DNA without and with
MolYsis treatment, respectively. The percentage of bacterial
DNA was significantly different between the pre-treated and
the untreated samples (p = 0.0207) (Supplementary Table S4).
In conclusion, these studies reveal that high quality microbial
gDNA was obtained from PJT on BCB samples pre-treated and
untreated with MolYsis5.
SMg Pilot Study – DNA Sample
Preparation Method for Further Assays
Two DNA samples (from the same BCB inoculated with a PJT
clinical sample) extracted using each of the two DNA sample
preparation methods [pre-treated (S1b) and untreated (S1c)],
were sequenced using illumina MiSeq sequencing technology.
In total, 14,785,194 and 14,078,494 raw reads were obtained
from the DNA pre-treated and untreated with MolYsis5,
respectively. The two samples were analyzed for the presence
of contaminant DNA from human and horse sources in
order to determine the proportion of contaminant reads. After
preprocessing raw reads, we mapped the remaining reads against
a set of human and horse reference genomes. We detected
a 16-fold increase in the number of reads mapping to horse
and a 19-fold increase in the number of reads mapping
to human in the sample untreated with MolYsis5 (Table 2
and Figure 3).
One of the key issues in clinical metagenomics is to remove the
host DNA without a substantial loss of bacterial DNA. Samples
treated with MolYsis5 before DNA extraction with QIAamp
BiOstic seemed to be a suitable DNA preparation method to
continue with SMg from BCB.
Shotgun-Metagenomics
Shotgun-metagenomics sequencing of DNA from clinical
samples resulted in a mean number of 10,277,311 reads per
sample (range 7,236,776–16,172,074). Sequencing of DNA
from spiked samples produced a mean number of 9,831,669
(range 6,857,300–11,884,076) reads, and 11,192,852 total reads
were obtained from sequencing the negative control (DNA
without MolYsis5 treatment) (Supplementary Table S5). An
additional negative control pre-treated with MolYsis5 was
sent for sequencing, but no good library preparation could be
obtained due to low DNA yield (results not shown). Thus, only
the untreated negative control was used in the analyses.
Extracting Sufficient Bacterial DNA While
Removing DNA From Other Sources
In this study, raw reads were screened for the presence of reads
from the host, from the horse blood (added to the bottles to
enrich the BCB media), and from PhiX phage used as control
during the sequencing process.
Overall, DNA from clinical samples presented a mean
proportion of reads classified as human (0.07%), horse (0.61%),
and PhiX (0.08%) lower than one percent. Similar results
were observed when analyzing DNA from the spiked samples,
where the mean proportion of reads mapping to the reference
genomes of human were 0.26%, horse 0.56%, and to the PhiX
phage 0.10%. For both cases, more than 99% of the reads
did not map to any of the reference genomes used during
the alignment (Figure 3). A different pattern was observed
when analyzing the negative control, the mean proportion of
reads mapped to human (1.4%) and horse (87.6%), while for
the PhiX phage, no difference was observed (0.01%). Two
percent of the reads did not map to any of the reference
genomes (horse, human and PhiX) and were then used for
taxonomical analyses (Figure 3 and Supplementary Table S5).
Overall, samples untreated with MolYsis5 (NC and S1C)
presented more reads mapping to the horse and human
genomes. In addition, the proportion of reads mapping to the
horse genome is higher than the human genome in all the
samples (Figure 3).
After preprocessing the raw data, we obtained a mean
number of 9,510,050 (92.86%) reads from the clinical samples,
and 7,936,436 (86.80%) from the spiked samples, while from
the negative control only 187,094 reads (1.67%) remained for
taxonomical analyses (Supplementary Table S5).
Kraken was used to assign a taxonomic label to each read for
estimating the relative proportion of species in the samples and
to determine the relative amount of sequences that came from the
known bacteria identified in the sample. Taxonomic classification
by Kraken when analyzing data from clinical samples identified
a median of 96.08% (IQR, 93.85–97.07%; range 85.7–98.6%)
bacterial reads. Spiked samples presented a median of 98.7%
(IQR, 96.90–98.70) bacterial reads, while for the negative control,
the proportion of bacterial reads was 30% (28,058 reads)
(Supplementary Table S6). In addition, when comparing the
pre-treated (sample S1b) and the untreated sample (sample S1c)
more reads were classified as bacterial reads (95.74%) for the pre-
treated sample than for the untreated sample (86.89%). Overall,
two percent more bacterial reads were obtained from the spiked
samples than in the clinical samples. Additionally, treatment of
the sample with MolYsis5 prior to DNA extraction resulted in
a higher proportion of bacterial reads when compared with an
untreated sample.
When estimating the number of reads classified at the genus
and species level (inferring the abundance of the number of
individuals from each taxon by correction for genome length
into abundance estimates by Bracken), it was on average higher
than 97.7% for both taxonomic levels (genus and species) and for
both sample types (DNA from spiked and clinical specimens).
In the negative control, 30.1% of the reads were classified to
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TABLE 2 | Reads affiliated to human and horse genomes when sample was treated (1b) and untreated with MolYsis5 (1c).
Sample code DNA preparation method Reads analyzed Human reads (%) Horse reads (%)
Treated (1b) MolYsis5 + BiOstic 13,417,582 14,521 (0.01) 135,751 (0.9)
Untreated (1c) BiOstic 12,698,920 249,520 (0.1) 2,365,316 (16.7)
FIGURE 3 | Proportion of the contaminant reads that mapped to PhiX, horse and human reference genomes or to multiple genomes. S1–S9, clinical samples;
PC1-3, spiked samples (positive controls); NC, negative control. aSamples untreated with Molysis5.
the genus and species level while the rest remained unclassified
(Supplementary Table S7).
Identification of Bacterial Species
Reported as Common Cause of PJI by
SMg
Nine of the PJT clinical samples in this study had previously been
analyzed using a conventional and a BCB method (Sanabria et al.,
2019). Bacterial identification for both methods was done using
MALDI-TOF. According to the results obtained from the BCB
method, S. aureus was identified in sample 1 (S1b), 2 (S2), 3 (S3),
4 (S4), and 7 (S7). Enterococcus faecalis was identified in sample 6
(S6), while in sample 8 (S8) and 9 (S9) Staphylococcus epidermidis
was found (Table 3).
All bacterial species identified from the BCB culture method
were detected by Kraken and MetaPhlAn, and they were
found to be the most abundant species present in the sample
(Supplementary Figure S2). The mean rate of the most abundant
bacteria in the clinical samples were 97.9 and 99.2% for the spiked
samples when using Kraken/Bracken. Similar results were found
using MetaPhlAn2, with 99.2 and 96.9% mean rates for clinical
and spiked samples, respectively.
The conventional culture results were all negative in
samples S7–S9, while the BCB method and the SMg were
consistent concerning bacterial species found (Table 3).
Bacteria detected by the conventional methods and by
SMg (Kraken/Bracken and MetaPhlan2) are listed in
Table 3. The taxonomic classification results for each
sample type excluding the negative control as estimated
by Kraken/Braken are presented in Figure 4. Similarly,
a heat map representing the relative abundance at the
species level as estimated by MetaPhlAn2 can be found in
Supplementary Figure S3.
Additionally, we tested the influence of downsizing the
number of reads (by subsampling reads) in the estimation
of abundance of species present in both the clinical and
spiked samples. We observed that the number of species
detected is higher at increasing sequencing depths and
that the taxonomical distribution did not change. The
potential pathogen species found in culture could still
be detected even if a smaller proportion of reads were
subsampled (10%). A rarefaction curve was used as a
qualitative method to estimate the species abundance as a
function of sequencing depth (Supplementary Figure S4).
Rarefaction curve reaches plateau just for a few samples
suggesting that saturation in sequencing was not achieved
and deeper sequencing is required to detect all the species
present. However, estimating the diversity is not the end point
in PJI diagnoses.
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TABLE 3 | Microorganisms identified in the samples using laboratory and SMg methods.
Sample Microorganism identified
Laboratorya (MALDI-TOF) SMg
No Code BCB Conventional Kraken/Bracken MetaPhlAn2
1 S1b S. aureus S. aureus S. aureus (99.6%) S. aureus (100%)
2 S2 S. aureus S. aureus S. aureus (99.5%) S. aureus (100%)
3 S3 S. aureus S. aureus S. aureus (99.9%) S. aureus (100%)
4 S4 S. aureus S. aureus S. aureus (89.8%) S. aureus (100%)
5 S5 S. aureus S. aureus S. aureus (99.8%) S. aureus (100%)
6 S6 E. faecalis E. faecalis E. faecalis (99.9%) E. faecalis (99.9%)
7 S7 S. aureus No growth S. aureus (99.9%) S. aureus (100%)
8 S8 S. epidermidis No growth S. epidermidis (95.8%) S. epidermidis (99.9%)
9 S9 S. epidermidis No growth S. epidermidis (97.7%) S. epidermidis (99.9%)
10 PC1 S. aureus NA S. aureus (99.9%) S. aureus (100%)
11 PC2 E. coli NA E. coli (99.7%) E. coli (90.7%)
12 PC3 S. aureus NA S. aureus (97.3%) S. aureus (100%)
aResults from our previous study (Sanabria et al., 2019), BCB method and conventional method. PJT, Periprosthetic joint tissue; BCB, Blood culture bottle; SMg,
shotgun-metagenomics; S1–S9, clinical samples; PC1-3, spiked samples (positive controls); NC, negative control; NA, not applicable.
FIGURE 4 | Stacked bar plot displaying relative abundance of bacteria at the species level as estimated by Kraken/Bracken in positive BCBs with PJT. Y-axis is split
in two parts, and each part with their own linear scale. From 0 to 0.2 the scale highlights the small values of species relative abundance. S1-S9, clinical samples;
PC1-3, spiked samples (positive controls).
Reads belonging to spiked samples were mapped against the
reference genomes of the respective strains used for spiking. For
S. aureus and E. coli, more than 98% of the genome was covered
with at least 4× depth. We obtained a genome coverage depth of
775X for the sample spiked with S. aureus (PC1) and 209X for
the sample spiked with E. coli (PC2). In the sample spiked with
S. aureus and C. acnes, no reads were observed when mapping
against C. acnes reference genome; instead 99.98% of the reads
mapped to the S. aureus reference genome, covering 99.5% of its
genome (Supplementary Table S11).
Other Bacteria and Possible
Contaminants Detected by SMg
In addition to the metagenomic reads belonging to the same
bacteria found by the conventional methods, reads belonging
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to other bacterial species were also found by Kraken. Their
respective abundance was estimated by Bracken in the clinical
samples (mean: 1.98%; range 0.07–10.21%), and in the spiked
samples (mean: 0.12%; range 0.06–0.23%). For each of the sample
types, we provide the respective Sankey flow diagram with the
classification results from Kraken (Supplementary Figure S5).
Reads belonging to Staphylococcus argenteus were found
in samples, S1(a, b, c), S3 S4, S5, and S7 always at the
same relative abundance (0.02%) and in samples S8 and S9
at a lower abundance (0.000422 and 6.043e-05, respectively).
This bacterial species was not found in the negative control
(Figure 5). The most abundant bacterial species found by
Kraken/Bracken in the negative control were Bacillus cereus
(81.5%), S. aureus (10.3%), Bacillus weihenstephanensis (1.2%),
and E. coli (0.88%) (Figure 5). MetaPhlAn did not identify
B. cereus and B. weihenstephanensis, but instead identified
the yeast Saccharomyces cerevisiae as the most abundant
microorganism found in the negative control (72.5%). S. aureus
was also found by MetaPhlAn2 at a relative abundance of
14.7%. E. coli was not detected but instead we found Escherichia
unclassified (4.1%) which means “an unknown species in the
genus Escherichia.”
When analyzing the clinical and spiked samples, we found
B. cereus in all the samples in a very low abundance (mean,
0.0016%). It was 12-fold more abundant (0.02%) in the
sample untreated with MolYsis5 (sample S1c), supporting that
it is a contaminant in this study. S. aureus was found by
Kraken/Bracken in the negative control (10.3%), as well as in
samples S6, S8, S9 and in the sample spiked with E. coli with a
very low occurrence (mean, 0.58%; range, 0.03–1.2%).
DISCUSSION
Here we demonstrate proof of concept that it is possible to
perform SMg directly on PJT from BCBs with the potential of
pathogen identification in PJI diagnosis. Culturing of PJT on BCB
was the starting point for our study, and we validated our findings
by comparison with conventional culturing methods, where we
already knew the outcome, i.e., complete microbiological data
from culturing were available for all samples.
To the best of our knowledge, this is the first study applying
SMg to Bact/Alert R© BCBs (bioMérieux) inoculated with PJT.
Sample type greatly influences the composition of sequencing
reads, and due to the complexity of both the BCBs and the
PJT specimens, sample preparation and bacterial enrichment
methods need to be specifically adapted.
It is well-known that the success of metagenomics is highly
dependent on the quality and quantity of DNA extracted from
a given specimen (Schlaberg et al., 2017). Therefore, sample
preparation methods need to be developed and improved to
effectively reduce the amount of host nucleic acids, lyse host
cells to release intracellular organisms and lyse different types
of microbial cells to release nucleic acids, without affecting the
quantity of targeted nucleic acid in the sample (Forbes et al.,
2018; Vijayvargiya et al., 2019). Here we demonstrated that the
use of MolYsis5 kit together with BiOstic kit is an effective sample
preparation method for performing SMg directly from BCBs
inoculated with PJT. Our DNA preparation method resulted in
high quality microbial DNA from all samples, both with and
without human DNA depletion, allowing downstream SMg.
Thus, we conclude that preanalytical reduction of the human
DNA load improved the output of targeted sequence reads.
This is important since DNA samples overwhelmed with human
DNA sequences affect the sensitivity for the detection of
bacteria that occur in low abundance in clinical specimens.
In addition, we screened the samples and removed reads
belonging to the horse genome, since horse blood was used
as enrichment supplement for the BCB, which may affect the
sensitivity for bacterial detection as such. Moreover, this makes
the method more expensive, creates the need of subtracting
the human and horse sequences during the bioinformatic
analysis, which delays the analyses, and it requires a significant
computational power (Hasan et al., 2016). Overall, our method
consistently generated high DNA yield quantity/quality, removed
efficiently human/horse DNA (<1%) and there was no inhibition
observed during the SMg library preparation, allowing further
sequencing process.
In order to select samples suitable for sequencing, one of
the main criteria that was considered, was the bacterial DNA
concentration measured by qPCR. We observed that samples had
to be diluted to get amplification signals. qPCR results could not
be considered as selection criteria. In addition, the concentration
of bacterial DNA from qPCR did not correlate with the bacterial
rate obtained from the classification of the sequencing reads
(median of 96.08%). This result was not surprising since there
are several factors that can affect the qPCR amplification,
among them: the presence of amplification inhibitors commonly
found in BCBs formulations (e.g., the anticoagulant, sodium
polyaneththolesulfonate SPS) (Mäki, 2015), unspecific primer
binding to host DNA which decreases the sensitivity and
specificity, and the less likely in this case, due to an overload of
eukaryotic DNA (since low horse and human DNA were found
in the sequencing reads). However, the DNA preparation tool
MolYsis which eliminates the human background, also removes
other PCR-inhibiting substances contained in BCBs, like SPS
(Gebert et al., 2008).
Methods for the preparation of bacterial DNA from BCBs (BD
BACTEC, Becton Dickinson Sparks, MD) using SMg have been
reported earlier but for bloodstream infection diagnosis (Anson
et al., 2018). However, the methods included a pre-treatment
by differential centrifugation to remove human cells and DNA
purification with SPRI beads prior to sequencing. In their study,
the use of BiOstic kit provided a higher DNA yield than Molysis
Plus (430× greater), and the mean DNA yield obtained was lower
(E. coli, 39.3 ng/µL and S. aureus, 11.5 ng/µL) than the DNA yield
obtained in our study (Mean DNA concentration: 84.23 ng/µL
for MolYsis5 treated samples and 65.28 ng/µL for untreated
samples). These differences in result may be due to the type of
clinical specimen inoculated into the BCBs, the effectiveness of
the pre-processing and purification step, in addition to the fact
that the BCBs belong to different brands.
Our results showed that MolYsis5 kit together with BiOstic
kit was an effective DNA sample preparation method for the
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FIGURE 5 | Sankey visualization of the absolute read counts as estimated by Kraken/Bracken from the negative control sample. D, Domain; P, Phylum; F, family; G,
genus; D, domain.
detection of the PJI related species tested here. Many bacterial
and fungal species have been reported as being detectable after the
use of MolYsis (Horz et al., 2010; Thoendel et al., 2016; Schmidt
et al., 2017; Krohn et al., 2018). However, we are aware about
potential limitations that should be taken into consideration
when using MolYsis in the clinical diagnostics. Sample pre-
treatment with MolYsis involves lysis of human cells prior to
degradation of bacterial cell walls, allowing digestion of human
DNA by DNAse treatment (Thoendel et al., 2016). The use of
MolYsis provides a solution for the removal of host DNA and
enrichment of intact microorganisms (Votintseva et al., 2017).
However, free floating DNA is removed. This raises a question
about which bacterial DNA is removed during the MolYsis
treatment. Bacteria with weak or absent cell walls will be removed
by the use of Molysis prior to DNA extraction. Among them,
Mycoplasma, Ureaplasma, or Chlamydia, although unusual, are
among the many organisms capable of causing PJIs (Geipel, 2009;
Rieber et al., 2019). In addition, bacteria previously exposed to
cell wall-targeting antibiotics will also be lysed and removed by
the Molysis (Horz et al., 2010). This in turn raises some concerns
about the proposed usefulness of MolYsis for the diagnosis of
PJI when these bacteria are causing the infection. In these cases,
sample pre-treatment with MolYsis should be avoided. DNA
extraction with BiOstic without MolYsis pre-treatment can be
used instead since good results were also obtained when using
this approach in our study (sample S1c, untreated with MolYsis).
SMg for diagnosing PJI directly from tissue specimens has
been tested (Ruppé et al., 2017). However, from a huge cohort
of samples collected (n = 179), only few (n = 24) could
be sequenced due to insufficient amounts of bacterial DNA
recovered from the samples. SMg directly from sonication fluid
(from orthopedic devices), has been tested as well, and this
is the specimen related to PJI most extensively studied in
metagenomics approaches (Thoendel et al., 2016, 2017, 2018;
Street et al., 2017; Sanderson et al., 2018). Despite all these
promising efforts on metagenomics for diagnosing PJI, direct
sequencing of nucleic acids obtained from biological samples
results in a high background of DNA, mainly derived from the
host, hindering the detection of pathogens causing PJI. Thus, all
these studies support clearly that the main challenge has been
recovering enough bacterial DNA. Our approach was therefore
to test the use of SMg directly on BCBs inoculated with PJT to
try to solve the limitations observed when using SMg directly
on PJI specimens.
In our study, predominant bacterial species in PJT from BCBs
determined by SMg, were 100% concordant with the results
obtained from the BCB culture method. Results were consistent
with respect to both the genus and species levels. We were able
to detect S. aureus, S. epidermidis, E. faecalis, and E. coli in the
samples, indicating the potential of the method for detection of
species commonly related to be the cause of PJI. The predominant
species (mean rate: 97.9%), reads belonging to other bacterial
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species were also found by the taxonomical classifier in a very low
proportion (mean rate: 1.98%).
Apart from the development and/or improvement in the DNA
sample preparation methods, one of the greatest challenges in
the use of SMg for identification of pathogens is the type of
controls (Couto et al., 2018). Positive controls should represent
the range of organisms that can be encountered in the clinical
specimen (Greninger and Naccache, 2019). In this study, three
spiked samples were included as positive controls. Two of them
spiked with one bacterial species (S. aureus or E. coli) and one
with two bacterial species (S. aureus and C. acnes). High breadth
and depth coverage were obtained when mapping the SMg reads
to S. aureus or E. coli reference genomes, respectively. However,
C. acnes was not found in the SMg taxonomical analyses of the
spiked control sample. It could be several reasons for this, but we
believe that it was due to mistakes in the experimental design.
S. aureus and C. acnes were spiked into the BCB at the same
time and we know from our previous study (Sanabria et al., 2019)
that C. acnes grows slower (mean time to detection: 8.7 days)
than S. aureus in the Bact/Alert R© BCBs. The positive control was
incubated in an aerobic BCB until positive, i.e., in this case 10.3 h
after incubation. We believe that the absence of reads belonging
to C. acnes is due to the fact that the bacterium did not have
enough time to grow. In addition, S. aureus might be a strong
competitor. Another possible explanation could be incomplete
lysis of C. acnes during the DNA sample preparation and the lack
of sensitivity of the SMg to detect the anaerobic C. acnes.
For the case of the negative control, we used a BCB medium
enriched with horse blood and inoculated with sterilized tissue
from a donor without suspicion of infection. We consider that
this negative control adequately reflects the contaminant or
background microorganisms originating from tissue specimens,
BCB media, horse blood, reagents, the environment and other
sources as from other samples and sequencing runs (Eisenhofer
et al., 2019; Huang et al., 2019). Results showed that from 93,502
reads, only 28,194 could be classified (30%).
In the negative control, we found taxa reported as common
contaminants (DNA extraction blank controls and no-template
controls) (Eisenhofer et al., 2019), e.g., Bacillus, Staphylococcus,
Enterococcus and Streptococcus. We also found some reads
classified as B. cereus in several of the clinical samples (in a
very low abundance, mean: 0.0016%) and this bacterium was
found 12-fold more abundant (0.02%) in the sample not treated
with Molysis5 (sample S1c). Bacillus spp. is often considered
a contaminant when it is isolated from BCBs and in negative
controls (Doern et al., 2020). However, the significance of this in
SMg on samples from BCBs is unknown.
We also found some reads assigned to S. aureus (10.3%)
and E. coli (0.88%) in the negative control. Since these bacteria
are among the most common causes of PJI (Tande and Patel,
2014; Izakovicova et al., 2019), these reads were evaluated by
aligning the reads against the reference genomes of the strain with
the highest assignment number of reads. When visualizing the
mapping results, reads mapped with genetic areas belonging to
coding sequences annotated as RNAs with a very low coverage
depth, and they were not distributed all over the genomes.
These may be reads originating from laboratory, in silico or kit
contaminants. Contamination is one of the main concerns in PJI
diagnostics and even more in metagenomic sequencing.
Reports have demonstrated that even the commercial kits
for DNA extraction and library preparation are potential for
contamination leading to misinterpretation of sequencing data
from clinical specimens (Salter et al., 2014; Eisenhofer et al.,
2019). It is therefore recommended to include and sequence
negative controls when performing SMg studies.
The spectrum of organisms defined as reportable by SMg
assays should be defined, and organisms determined to be
background contaminants or clinically insignificant should be
described (Gu et al., 2019). Defining a contaminant is not clear
for blood cultures in the laboratory and present a challenge for
SMg (Greninger and Naccache, 2019). Many factors should be
considered when interpreting the results from SMg especially
because the results are highly dependent on the database used
for the analysis, which could be incomplete for rare pathogens
or biased toward certain organisms, in addition to the fact
that contamination with normal flora and reagents are a
common occurrences that can limit specificity (Gu et al., 2019).
Consequently, it is very important to be careful when analyzing
the clinical significance of the results.
The most common in silico decontamination method in
practice is the removal of sequences below a determined
detection threshold (Davis et al., 2018). Usually, software used
for taxonomical classification such as Kraken can predict a lot
of species. Although we have limited clinical data to distinguish
between true PJI and contamination, we tested the effect of
several thresholds on the estimation of species abundance in the
samples. We observed that the number of species detected in the
samples are highly dependent on the threshold value used during
the analyses (Supplementary Figure S6 and Supplementary
Table S10). The results presented here prove that for species
detection, thresholds may often lead to different inferences while
interpreting the diagnostic results. Consequently, when using
SMg, thresholds need to be validated in each specific case for
an accurate interpretation of the results (Schlaberg et al., 2017).
In our case, unfortunately we cannot allow to give an exact cut-
off value, due to limited access to clinical data of our samples.
However, others have set optimal thresholds for differentiating
low-level contaminations from true PJI when using SMg on
sonication fluid (Street et al., 2017; Ivy et al., 2018).
There is no standard method for interpreting metagenomic
sequencing results. Contaminant DNA in SMg is a challenge
for clinical interpretation of metagenomics data (Peel et al.,
2016; Thoendel et al., 2016; Ruppé et al., 2017; Street et al.,
2017; Thoendel et al., 2017; Ivy et al., 2018; Simner et al.,
2018; Thoendel et al., 2018). We cannot exclude the possibility
of contamination in our study. As in most studies, all our
samples contained read identifications for microorganisms other
than known or suspected pathogens. In order to determine if
the bacterial species found are infection inducing pathogens,
background contaminants or noise, we observed that there
are several aspects that can help to differentiate them, among
them: (i) The proportion of reads assigned to the species
present. The possibility of obtaining quantified abundances
of microorganisms is important for distinguishing causative
Frontiers in Microbiology | www.frontiersin.org 11 July 2020 | Volume 11 | Article 1687
fmicb-11-01687 July 17, 2020 Time: 15:24 # 12
Sanabria et al. Shotgun-Metagenomics and Prosthetic Joint Infection
pathogens (Greninger and Naccache, 2019). In our case, we
considered that a high proportion of reads belonging to the
most abundant bacteria present in the samples (97.9% mean
rate) could be an indicator of the bacterium causing the
infection. (ii) Genome coverage and the proportion of the
genome covered, higher depth and breadth coverage expected
for the pathogen species with respect to other species detected
by the taxonomical classifier. For pathogen detection it is even
more important because sequencing depth also affects analytic
sensitivity (Schlaberg et al., 2017; Couto et al., 2018). (iii)
Comparison with respect to the species and to the proportions
of reads found in the negative control and in the spiked samples,
and (iv) To set an appropriate threshold, for pathogen detection.
Regarding this, it is important to limit the number of species
identified, for minimizing false-positive results, increasing the
detection rate of potential true pathogens and reducing the
misclassification of other species related signals as potential
pathogens (Couto et al., 2018). It is important to consider
that setting up cut-off values for pathogen detection may result
in decreased sensitivity. Therefore, it is better to rely on the
relative abundance of bacterial species in addition to the genome
coverage and the proportion of the genome covered.
It is important to predict the level at which samples should
be sequenced to prevent excessive sequencing and to answer our
biological question (Sims et al., 2014). The relatively high cost for
metagenomic sequencing is a major limitation for application in
the clinical setting (Ruppé et al., 2017). Significant reduction in
the cost of metagenomic sequencing is required for moving up in
the diagnostic pipeline (Greninger, 2018). Multiplexing samples
offers the possibility of decreasing the costs by decreasing the
number of reads per sample. The question is how many reads
are needed to answer a particular question (Mulcahy-O’Grady
and Workentine, 2016). In this study, we wanted to assess the
potential of SMg for the detection of bacterial species known
as common causes of PJI. We analyzed the effect of reduction
in sequencing depth (expressed as proportion of reads) for the
detection of potential PJI pathogens and, we observed that even
while using the minimal proportion of reads subsampled (10%)
we were able to detect S. aureus (Supplementary Figure S7).
This result suggests that presumably less sequencing depth is
needed for detection of common PJI pathogens, more samples
can be multiplexed in a sequencing lane, accomplishing a lower
cost per sample. However, it is important to be aware that
the impact of a lower sequencing depth to provide additional
information beyond pathogen detection was not considered in
this study. Nevertheless, the results obtained in this study open
the possibility for studying antibiotic resistance determinants and
virulence genes at further stages.
Our study has the following technical limitations: (1) Low
total number of clinical samples analyzed trough shotgun-
metagenomics (n = 9) and just one sample per patient. (2)
Limited clinical data about the patients making it difficult to
define a sample selection criterion to distinguish between true
PJI and contamination; (3) Negative samples by conventional and
BCB culture methods were not included. (4) Only aerobic BCBs
were included. (5) Absence of polymicrobial samples (all samples
tested were monomicrobial by culture). (6) In comparison with
the conventional and the BCB culture methods, the application of
SMg is limited by the expensive equipment and operational costs.
The use of clinical metagenomics approaches will increase
during the next years in research and in medical microbiology
laboratories (Deurenberg et al., 2017). The application in
clinical microbiology is still in its infancy, which encourage
further research on alternative and complementary tools for PJI
diagnosis. There are ongoing discussions about the obstacles
associated with the adoption of metagenomics in diagnostics and
their clinical utility (Greninger, 2018; Chiu and Miller, 2019; Han
et al., 2019). However, we do not believe that SMg can replace
conventional culturing, but it can be a potential diagnostic tool
to support conventional culture in cases when PJI diagnosis
is challenging, e.g., with fastidious organisms, discrepancies
between conventional methods, or in culture negative cases.
In conclusion, our DNA preparation method resulted in high
quality microbial DNA from all PJT samples, both with and
without human DNA depletion, allowing downstream SMg. By
SMg we were able to identify relevant PJI pathogens, and all
bacteria identified by culture were also identified through SMg.
A high enough sequencing depth was obtained indicating that it
is possible to multiplex samples reducing costs considerably. We
achieved a high sequencing quality, low human DNA content,
high number of reads and complete genome coverage of sufficient
depth that technically can be used for AMR prediction, virulence
gene detection and bacterial typing.
We consider this an essential step in further studies for solving
the challenges presented in PJI diagnosis, e.g., when bacteria are
not detected by the laboratory methods but there is still clinical
signs of the presence of infection (Peel et al., 2016). It is still
possible to extract DNA from a negative BCB and analyze if
pathogenic bacteria are present. In fact, the results of SMg can
also be valuable even when concordant with laboratory results,
not only providing a guarantee that the laboratory diagnosis
is correct, but also allowing extra information, e.g., detecting
coinfections and/or predicting antimicrobial susceptibility. Our
results can be useful for further validation and standardization
for the use of SMg on BCBs inoculated with clinical samples
for routine diagnostics of pathogens. It is still a long way until
SMg can be used in the clinical microbiology laboratory, but
this SMg approach presents an alternative tool in PJI diagnosis,
complementing the currently available tools.
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